High-quality Semaglutide Lyophilized Powder Complete Batch COA Report DPP-4 Resistant Albumin-Binding Polypeptide for Hepatic Lipid Cell Culture Acade
TDS 4 Inquiries
12020-86-9
Pharmaceutical Grade
99%
guangzhou
band
2mg/vial 10vials/box
2026-07-25
Tirzepatide,Retatrutide,Semaglutide,GHK-Cu
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceMGF stands for Mechano Growth Factor. MGF is a peptide for tissue repair that promotes the expansion of tissue stem cells. It is an insulin-like growth factor-1 (IGF-1) splice variant. Research suggests MGF promotes healthy tissue regeneration, wound repair, cardiac repair, and skeletal muscle recovery.Certificates
-
TDS
Basic Info-
Product Name:
MGF
Other Name:MGF;Anti-STAT5A, C-Terminal antibody produced in rabbit;Mammary gland factor;STA5A;Anti-STAT5A antibody produced in rabbit;STAT5, His tagged human;STAT5A;MGF(5MG)
CAS No.:12020-86-9
Molecular Formula:FKLiMgO5Si2+
InChIKeys:URDVXLJHPPPBHL-UHFFFAOYSA-M
Molecular Weight:225.51
EC Number:200-001-8
Categories:
Characteristics-
Density:
2.85 g/cm3
Critical Temperature & Pressure:-20°C
Research-
Class:
GLP-1R agonist
Status:FDA-approved (Ozempic / Wegovy / Rybelsus)
Mechanism:Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.
Activity note:Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).
Source:Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI
Clinical Development:FDA:Ozempic, Wegovy, Rybelsus (approved 2017-12-05)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
NEJM: Wilding et al. (2021) — STEP-1; NEJM: Marso et al. (2016) — SUSTAIN-6; J Med Chem: Lau et al. (2015) — Discovery of Semaglutide; FDA: Ozempic (NDA 209637)
Disclaimer:Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Semaglutide,GHK-Cu
-
Location:
RM 701, UNIT 108, 7/F, TWR B NEW MANDARIN PLAZA 14 SCIENCE MUSEUM RD TSIM SHA TSUI HONG KONG
-
Year of Establishment:
2026
-
-
Inquiry History4 Inquiries
Country Product Purchase Quantity Date Posted 
Australia
MGF
50 Dec 22, 2023 
Philippines
MGF
10 MG May 26, 2026 
United States
MGF POWDER (not vials)
1 G Mar 16, 2026
United States
factory hot sale MGF,Mechano grow factor 98% Powder IGF-1 EC 99% White powder with good price
1000 MT Nov 3, 2023 Post an enquiry for this product
